Bessemer Group Inc Halozyme Therapeutics, Inc. Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 389 shares of HALO stock, worth $18,493. This represents 0.0% of its overall portfolio holdings.

Number of Shares

389

Previous 302 28.81%

Holding current value

$18,493

Previous $16,000 37.5%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$51.3 - $64.42 $4,463 - $5,604	87 Added 28.81%	389 $22,000
Q2 2024 Aug 13, 2024	BUY	$37.81 - $52.4 $7,221 - $10,008	191 Added 172.07%	302 $16,000
Q1 2024 May 13, 2024	SELL	$33.68 - $41.95 $3,368 - $4,195	-100 Reduced 47.39%	111 $5,000
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $21,730 - $26,241	-596 Reduced 73.85%	211 $8,000
Q2 2023 Aug 10, 2023	BUY	$30.28 - $38.74 $19,197 - $24,561	634 Added 366.47%	807 $29,000
Q1 2023 May 10, 2023	SELL	$32.86 - $55.7 $145,175 - $246,082	-4,418 Reduced 96.23%	173 $6,000
Q4 2022 Feb 13, 2023	BUY	$40.06 - $59.44 $178,226 - $264,448	4,449 Added 3133.1%	4,591 $262,000
Q3 2022 Nov 09, 2022	BUY	$38.53 - $51.78 $5,471 - $7,352	142 New	142 $6,000
Q1 2022 May 12, 2022	SELL	$31.97 - $41.06 $10,550 - $13,549	-330 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$38.84 - $51.31 $16,701 - $22,063	-430 Reduced 56.58%	330 $15,000
Q1 2021 May 13, 2021	SELL	$39.51 - $51.45 $5,531 - $7,203	-140 Reduced 15.56%	760 $31,000
Q4 2020 Feb 09, 2021	SELL	$25.81 - $43.62 $10,324 - $17,448	-400 Reduced 30.77%	900 $38,000
Q3 2020 Nov 12, 2020	SELL	$25.74 - $29.63 $18,018 - $20,741	-700 Reduced 35.0%	1,300 $34,000
Q2 2020 Aug 05, 2020	BUY	$16.25 - $26.81 $32,500 - $53,620	2,000 New	2,000 $54,000
Q2 2018 Jul 25, 2018	SELL	$16.87 - $20.3 $323,431 - $389,191	-19,172 Closed	0 $0
Q4 2017 Jan 30, 2018	BUY	$16.75 - $20.8 $321,131 - $398,777	19,172	19,172 $388,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Halozyme Therapeutics, Inc. Transaction History